Items where authors include "Morgan, G."

Article

Pawlyn, C. orcid.org/0000-0002-7190-0028, Schjesvold, F.H. orcid.org/0000-0003-1096-0569, Cairns, D.A. orcid.org/0000-0002-2338-0179 et al. (13 more authors) (2024) Progression-free survival as a surrogate endpoint in myeloma clinical trials: an evolving paradigm. Blood Cancer Journal, 14. 134.

Kelly, C., Crawford, E., Morgan, G. et al. (1 more author) (2022) Assessing a video-based intervention to promote parent communication strategies with a deaf infant: a feasibility and acceptability study. Journal of Clinical Medicine, 11 (18). 5272. ISSN 2077-0383

Collins, G., Fyson, R., Morgan, G. et al. (2 more authors) (2022) The power threat meaning framework: development of a document for use in intellectual disabilities services. The Bulletin of the Faculty for People with Intellectual Disabilities, 20 (1). ISSN 2056-3094

Hand, R.A. orcid.org/0000-0002-3166-1798, Bassindale, T. orcid.org/0000-0002-4023-6478, Turner, N. orcid.org/0000-0002-9380-5291 et al. (1 more author) (2021) Application of comprehensive 2D chromatography in the anti-doping field: sample identification and quantification. Journal of Chromatography B, 1178. 122584. ISSN 1570-0232

Kelly, C., Morgan, G., Bannard, C. et al. (1 more author) (2020) Early pragmatics in deaf and hard of hearing infants. Pediatrics, 146 (Supplement 3). S262-S269. ISSN 0031-4005

Ürün, Y., Hussain, S.A. orcid.org/0000-0003-1552-511X, Bakouny, Z. et al. (13 more authors) (2020) Survey of the impact of COVID-19 on oncologists’ decision making in cancer. Jco Global Oncology, 6. pp. 1248-1257. ISSN 2687-8941

Hand, R.A. orcid.org/0000-0002-3166-1798, Piletska, E., Bassindale, T. orcid.org/0000-0002-4023-6478 et al. (2 more authors) (2020) Application of molecularly imprinted polymers in the anti-doping field: sample purification and compound analysis. The Analyst, 145 (14). pp. 4716-4736. ISSN 0003-2654

Kelly, C., Morgan, G., Freeth, M. et al. (2 more authors) (2019) The understanding of communicative intentions in children with severe-to-profound hearing loss. The Journal of Deaf Studies and Deaf Education, 24 (3). pp. 245-254. ISSN 1081-4159

Proceedings Paper

Pawlyn, C., Menzies, T. orcid.org/0000-0003-3896-7228, Davies, F.E. et al. (12 more authors) (2020) The Addition of Carfilzomib to a Lenalidomide-Based Triplet Improves Outcomes in Newly Diagnosed Transplant Eligible Myeloma Patients with Renal Impairment: A Subgroup Analysis of the Myeloma XI Trial. In: Blood. 62nd ASH Annual Meeting and Exposition, 05-08 Dec 2020, Virtual. American Society of Hematology , pp. 40-43.